10^th International Conference on Interventional Cardiology, Heart failure & Cardiovascular Medicine April 25-26, 2022 Tokyo, Japan

On the behalf of conference series academics, young researchers doctors, medical students, cardiologist and delegates and that person who is the front line of this barrier in covid 19 time

With the massive and ebullient presence of adepts, young and brilliant researchers, Professors, Doctors, and outstanding student communities, cardiology and vascular imaging gives an insight into the most recent research and cutting edge technology, which attracts enormous curiosity.

The purpose of the Interventional Cardiology Meeting is to bring together a multidisciplinary group of Scientists and Researchers, Professors, and Doctors from around the world to present and exchange cutting-edge ideas related to the Interventional Cardiology. Meeting promotes top-level research and to globalize the quality research in general, making discussions and presentations more competitive internationally and focusing attention on the recent outgrowths.

We looking ahead the outstanding meeting of all the dignitaries from different different national or international country and this program are slated on 29-30-2022 in Rome, Aland Island

 

The 10th International Conference on Interventional Cardiology, Heart failure & Cardiovascular Medicine which is going to be held in Tokyo, Japan during April 25-26, 2022. Warmly welcomes all participants to delight their gracious presence. It is highly committed event providing an international platform to interchange knowledge, share new visions in Cardiovascular Disease or Risk Reduction and all related subjects.

10th International Conference on Interventional Cardiology, Heart failure & Cardiovascular Medicine, will be organized around the theme “Advances of Interventional Cardiology in Scientific Era”

Interventional Cardiology 2021 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Interventional Cardiology 2021.

10th International Conference on Interventional Cardiology, Heart failure & Cardiovascular Medicine gives you an opportunity to broaden your thinking and knowledge by listening to ideas and theories and recent developments in Cardiology and Cardiovascular Medicine. International Conference can give you a wonderful opportunity to meet and interact with fellow researchers, experts across the World. It also allows you to meet new people.

This interventional cardiology will be a truly international event; we expect to welcome healthcare professionals from over 100 countries. We also have global faculty who are leading experts in their fields. Gain valuable awareness from these prominent professionals from skilled institutions.

Salient features

·       Keynote speeches and plenary talks by researchers all over the globe
·       Opportunity to meet globe expert’s in regenerative medical science
·       Posters, e-posters and video presentation by research community
·       International Certification by Organizing Committee
·       Publishing accepted abstracting International Journals
·       The study provides an in-depth analysis of the global Cardiology market

  Target Audience

·       Cardiology Researchers
·       Cardiology Scientists
·       Cardiology Investors
·       Cardiology Societies
·       Directors of Laboratories
·       Universities
·       Industries
·       Investigators
·       Post-Doctoral Fellows
·       Research and Diagnostic Laboratories
·       Clinical Fellows
·       Medical Devices companies
·       Pharmaceutical Companies
·       Business Entrepreneurs.

Track 1.

Heart Conditions and Disorders:

Cardiovascular diseases: Heart and veins are both affected by cardiovascular disorders. It is currently the primary cause of death. Variables associated with heart diseases include age, sex, tobacco usage, actual lethargy, excessive alcohol consumption, terrible food habits, and weight. Most often, vein blockages that stop blood flow to the heart or brain are what cause cardiovascular failures and strokes. Symptoms can include chest pain, discomfort in the arms, left shoulder, elbows, jaw, or back, difficulty breathing, feeling weak, or retching. People who have these signs should seek out clinical care right away.

• Heart failure
• Myocarditis
• Pulmonary heart disease
• Cardiomyopathy
• Cardiac arrest
• Alular heart disease
• Aortic aneurysm

Track 2.

Myocardial:

Cardiovascular failure is another name for myocardial localised necrosis. It occurs when the blood flow to a portion of the heart ceases or decreases, damaging the heart muscle. The most well-known sign, which can also affect the shoulder, arm, back, neck, or jaw, is discomfort or pain in the chest. Myocardial infarction classification;

• MI that develops out of the blue due to plaque erosion, rupture, fissuring, or dissection
• Ischemia-related MI
• sudden abrupt death or cardiac arrest
• a side effect of stents or coronary angioplasty
• Precisely related to percutaneous coronary intervention (PCI)
• known to be related to stent thrombosis during angiography or at autopsy
• Connected to CABG

Track 3.

Neurology and Cardiology:

Cardiology and nervous system science are related to the pathologic processes of the circulatory and anxious systems. The consistent communication between the heart and the mind has proven crucial in coordinating the fields of neurological and cardiovascular infections. There are too many problems with the neuron-cardiovascular link in terms of the physiological components of the body. This comprises:

• Stroke
• Stress
• Arrythmia

Track 4.

Cardiothoracic CT, MRI, and echocardiography:

Echocardiogram: An echocardiography is a test that uses high-frequency sound waves to transmit live images of the heart in order to examine the heart's structure and evaluate its capabilities. The image is referred to as an echocardiography. It yields no outcomes. Using echocardiography, a professional can identify: the thickness and growth of the heart's partition, the size and condition of the heart.

The strength of the heart's syphoning motion: assuming that the cardiac values are functioning properly. if the heart values are experiencing reverse blood leaking. In the unlikely event that heart values are too constrained. If a tumor or other unstoppable growth is present near the heart values

X-ray: X-ray uses radio waves and a strong attractive field to create images of the body's organs and tissues. X-ray filters are different from CT outputs and X-beams because they don't use potentially dangerous ionizing radiation. 3. Myocardial infarction (MI) and heart failure

Cardiovascular breakdown: Cardiovascular breakdown is the inability of the heart to pump enough blood to the body. Without sufficient blood flow, all significant bodily functions are disrupted. Warmth disappointment may affect the left or right part of the heart, or perhaps both at once. Heart failure types:

 

• Heart failure on the right side
• A left-sided cardiac condition
• Heart failure with diastole
• Failing heart in systole

Track 5.

Pediatrics and congenital cardiovascular disease:

Pediatric Cardiovascular Disease: Children with various heart problems are shown to have pediatric cardiovascular disease. The term "pediatric coronary illness" refers to a condition that alters how children's hearts pump blood. Among birth defects, pediatric cardiovascular infection is the most well-known. Abnormalities and delays in development

• An atrial sepal defect
• Cardiopulmonary Sepal Defect
• Aortic arc coarctation
• Right Ventricle with Two Outlets
• Anomaly of Epstein

Track 6.

Cardiovascular Pharmacology:

Cardiovascular pharmacology: This field of study deals with medications that are used to treat cardiovascular diseases. To treat various heart diseases, many medications are used. The following are a few examples of drugs used as cardiovascular drugs:

• Thrombolytic or blood thinners
• antiplatelet medicines
• Thrombolytic medicines
• ACE inhibitors, or angiotensin-converting enzyme inhibitors
• Anti-Angiotensin II receptors (ARBs)
• Diuretics
• inhibitors of calcium channels
• Vasodilators
• Digoxin

Track 7.

Hypertension and Obesity:

Hypertension: Hypertension is a serious condition that increases the risk of kidney, heart, brain, and other infections. The amount of blood your heart pumps and the degree of blood stream protection in your hallways both affects pulse.

Stoutness: Being overweight is a disease that includes an unnecessary ratio of muscle to fat. Weight is a medical problem that increases the risk of developing various infections and diseases like diabetes, hypertension, certain types of cancer, and coronary disease. Obesity causes:

• Active inactivity
• Overeating \genetics
• consuming lots of simple carbohydrates
• How often you eat
• Medications

Track 8.

Circulation: arrhythmia and electrophoresis:

Arrhythmia: An arrhythmia is a disruption in the normal electrical impulses that regulate heartbeat. It causes the heart to beat too quickly, too slowly, or in an erratic musical manner. Most arrhythmias are innocuous; some are not kidding or even perilous. The heart cannot pump enough blood to the body when the heartbeat is too rapid, too erratic, or both.

• Heart arrhythmia treatments include:
• procedures for electrophysiology
• Cardio version Implantable Cardioverter Defibrillator (ICD)
• Medical Management
• Pacemaker Implantation
• Trans esophageal Echocardiogram
• Heart Surgery

.Track 9.

Women’s Cardiovascular Health: Cardiac Problems during Pregnancy:

Heart Problems throughout Pregnancy: Cardiovascular problems during pregnancies include symptoms including fatigue, chest pain, windedness, swooning, and difficulty breathing while sleeping. Due to changes in volume and pulse during pregnancy, swooning occurs. Women's hearts frequently experience the following issues:

• Shunt injuries
• Blockage Lesions
• Intricate lesions
• A cyanotic heart condition

Track 10.

Cardio-oncology and nuclear cardiology:

Cardio-Oncology: Cardio-oncology is the study of cardiology that focuses on diagnosing, treating, and monitoring cardiovascular diseases brought on by radiotherapy and chemotherapy. Different cardiologists care for and monitor patients with coronary disease and cancer.

Atomic Cardiology: Atomic Cardiology takes into account the use of immune system techniques to evaluate the myocardial blood flow, the heart's ability to pump, and to visualise the size and location of a coronary episode. Myocardial perfusion imaging is the most frequently used atomic cardiology technique out of all of them.

Nuclear cardiology test types:

• Heart SPECT
• Heart PET-CT

Track 11.

Molecular and cellular cardiology:

Atomic cardiology: The study of the subatomic elements of cardiovascular science and infections of the human circulatory system. It focuses on identifying new mechanisms that control cardiovascular hypertrophy, ageing, and metabolic diseases with a specific focus on translating bench discoveries to fresh bedside methods and approaches.

Cardiovascular disease is the leading cause of death worldwide, according to cell cardiology. The flexible tool that induces ventricular breakage is heart redesign. The authors of this page describe the components of the human heart, evaluate its critical functions, and compare these functions under both normal and neurotic conditions.

Track 12.

Lipid ology:

The study of lipids includes cholesterol. It unearths particular medications for high cholesterol and other lipid issues. An iridologist studies how lipids and lipoproteins are digested in the body and works to find ways to lower the death rates associated with high cholesterol. Due to the rise in diseases like cardiovascular disease that are linked to high levels of cholesterol, there is a sector of capacity that is expanding. Lipid problems include:

• Hypercholesterolemia
• Hyperglyceridaemia
• Hypertriglyceridemia
• Hypolipoproteinaemia
• Hyperchylomicronaemia

Track 13.

Aesthetic Cardiology:

Through the assessment of individual risk and the early beginning of interventions to prevent, defer, or alter the progression of clinical atherosclerosis, which will be essential and furthermore after the appearance of suggestive coronary supply route illness, preventive cardiology has started to treat a variety of coronary infection risk factors and coronary course sickness. The main goal of preventive cardiology is to identify those who are at a high risk of developing cardiovascular disease. Cardiovascular disease can be prevented by engaging in regular exercise, eating less processed food, abstaining from tobacco use and excessive alcohol consumption, and maintaining normal blood sugar and LDL cholesterol levels.

Track 14.

Vascular Biology, Thrombosis, and Arteriosclerosis:

Arteriosclerosis: Arteriosclerosis refers to a disorder in which the veins that carry nutrients and oxygen from the heart to the rest of the body thicken and harden, limiting the flow of blood to the organs and tissues. This damage enables the development of plaque, which is a variety of substances on the corridor divider. These compounds include cholesterol and fat.

Atherosclerosis progresses in five stages;

• faulty endothelial function
• Formation of lipid layers
• Migration of eosinophils and smooth muscle cells into the vessel wall
• Formation of foam cells
•  Matrix extracellular degradation

Track 15.

Vascular Biology, Thrombosis, and Arteriosclerosis:

Arteriosclerosis: Arteriosclerosis refers to a disorder in which the veins that carry nutrients and oxygen from the heart to the rest of the body thicken and harden, limiting the flow of blood to the organs and tissues. This damage enables the development of plaque, which is a variety of substances on the corridor divider. These compounds include cholesterol and fat.

Atherosclerosis progresses in five stages;

• faulty endothelial function
• Formation of lipid layers
• Migration of eosinophils and smooth muscle cells into the vessel wall
• Formation of foam cells
• Matrix extracellular degradation

Thrombosis: Thrombosis is the process through which a blood clot, or thrombus, forms in a blood vessel. If the clot spreads to a vital organ of the circulatory system, including the brain or lungs, it can create major difficulties and block or obstruct blood flow in the affected location.

The two primary categories of thrombosis are:

• The blood clot that plugs a vein is referred to as venous thrombosis.
• The blood clot that plugs an artery is referred to as arterial thrombosis.

Blood vessel biology: The study of the biology of the cells that make up the arterial wall is known as vascular biology. The heart and blood vessels are part of it. The body's blood vessels are made up of veins and arteries that carry blood from the heart to other 

Track 16.

Image analysis and cardiovascular imaging:

Cardiovascular Imaging: Cardiovascular imaging is a diagnostic radiography that uses medical images to identify heart abnormalities and diagnose cardiovascular disorders. It is used to identify a variety of illnesses, including:

• Cardiovascular disease.
• Valve issues or heart failure.
• An attack of the heart's damage.
• Inherited cardiac conditions
• Pericarditis
• Heart tumors.

Image analysis involves breaking down an image into its basic elements and removing any pertinent information. Finding shapes, eliminating noise, counting objects, spotting edges, and generating statistics for texture analysis or image quality are just a few of the activities involved in image analysis. Here are some techniques for image processing:

• Image processing in analogue
• Digitization of images

Track 17.

Cardiology Clinical Case Reports:

A case report in medicine is defined as an extensive account of the symptoms, warning signs, diagnosis, treatment, and aftercare of a specific patient. Case reports may include the patient's segment profile, a surprise event, or an examination of previously unreported clinical cases.

Case lids Master reports on cardiology provide in-depth information on cardiology treatment and provide a framework for early warning signs of viability, bad circumstances, and cost.

Track 18.

Blood Flow in the Brain and Metabolism:

Cerebral Blood Flow (CBF): CBF is defined as the amount of blood that flows through brain tissue per unit mass per unit of time and is often measured in milliliter’s (ml) of blood. Single-photon outflow registered tomography (SPECT), positron discharge tomography (PET), X-ray with contrast agents, and blood vessel turn marking (ASL) X-ray are direct methods for determining CBF in human individuals.

Four main mechanisms regulate CBF:

• Metabolic regulation, sometimes known as "metabolic auto regulation"
• automatic pressure regulation
• Chemical regulation (by arterial pCO2 and pO2)
• Neural command

Digestion: Digestion is used to transmit all substance reactions recalled for moving forward with the cells' and the living thing's ongoing metabolic processes. Effectively, the two kinds of digestion are catabolism and anabolism. Catabolism suggests

Track 19.

Translational Cardiovascular Research:

According to Translational Examination in Cardiology, it is a method for utilising advanced systems to enhance their importance in the disciplines of cardiovascular disease, finding, and treatment to hasten logical disclosure into patient and future local area advantage. It focuses on fundamental clinical needs. It is specifically meant to enhance wellbeing outcomes in applied sciences. Different types of translational investigation:

• T1 analysis
• T2 analysis
• T3 analysis
• T4 analysis

Track 20.

Cardiology's Newest Research and Advances:

Flow and ebb Cardiology research: With the recent development of innovative techniques and tools, the diagnosis and treatment of cardiovascular diseases have improved significantly, saving numerous precious lives. At CWC 2022, examine the trends in momentum research in cardiology.

Cardiology advances: The new guidelines for revascularization, new advancements in the management of cardiogenic shock, novel stent innovations, and clinical preliminary data showing no benefit of discontinuing anti-inflammatory medication after stenting system are a few of the major advancements in cardiology that come to mind.

Track 21.

Cardiology Stem Cell Research and Regeneration:

One-dimensional organism Foundational microorganism research is an investigation into the characteristics of immature cells and their potential for use in medicine. Given that immature microorganisms are the beginning point, understanding their characteristics can help us understand how a healthy and ill body functions and maintains homeostasis. Five different types of developing microorganisms are explored;

• stem cells that are totipotent (or omnipotent)
• Pleiomorphic Stem Cells
• Several-Pose Stem Cells
• stem cells with oligopotency
• Universal stem cells

The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and estimated to reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022. The market for cardiac biomarkers is estimated to reach $7.2 billion by 2018, at a compound annual growth rate (CAGR) of 12.8% from 2013 to 2018.

The number of cardiac procedures performed increased steadily over the five years to 2017, providing overwhelming demand for operators in the Cardiologists industry. In particular, the growing burden of cardiovascular disease fostered increased demand. In addition, increasing rates of obesity and an aging baby-boomer population have resulted in an uptick in heart-related conditions. As a result, the early onset of chronic health conditions, such as heart disease, hypertension and diabetes, bolstered demand for industry services. . Improving economic conditions through 2022 are expected to underpin steady growth for cardiologists, though profit pressures will encourage consolidation in the industry.

The field of Medical Sciences has been witness to a series of developments in the last few years. We have been empowered with better drugs and cutting edge technology to treat life-threatening diseases. Over time, advances in technology have changed the way cardiology is practiced. We have more potent drugs, effective new diagnostic techniques, next generation medical technology and novel therapies for high risk patients, which have emerged and are likely to evolve further.

Not only is the pace of change in cardiology been faster than ever, but also the scope of cardiology practice has widened and requires closer interactions and deeper understanding other specialties. It is a real challenge to keep up to date with innovation, subspecialty developments in cardiology, rapid progress in basic, clinical and translational research, and changing guidelines. It is essential for the busy clinician to know what may really change practice, now and in the future, and what may improve current management of patients with cardiovascular disease.

Importance and Scope: -

World Cardiology Meeting will be the best platform for all the scientists, cardiologists, oncologists, electro physiologists, surgeons, nurses, research scholars, students who are working in this field to exchange their knowledge related to Cardiology and Cardiac Surgery. This international event is an effort to find an alternative for invasive imaging technique against heart diseases and heart failure conditions in adults & children.

Growth of Cardiology Market: -

North America is the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2018, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share.

Related Associations:

European Society of Cardiology
American Association of Heart Failure Nurses (AAHFN)
American Society of Nuclear Cardiology (ASNC)
American Society for Echocardiography
Pediatric Cardiology Associates

 

America

American Association for Thoracic Surgery, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Heart Failure Nurses, American Cardiology Association, American College of Cardiology, American Heart Association, American Society for Preventive Cardiology, American Society of Echocardiography, American Society of Hypertension, American Society of Nuclear Cardiology, American Stroke Association, Argentine Society of Cardiology, Arizona Society of Echocardiography, Brazilian Society of Cardiology, Brazilian Society of Hypertension, Canadian Association of  Cardiovascular Prevention and  Rehabilitation, Canadian Cardiovascular Society (CCS), Congenital Cardiac Anesthesia Society, Congential Heart Surgeon's Society, Northwest Association of Cardiovascular and Pulmonary Rehabilitation, The Society for Cardiovascular Angiography and Interventions Foundation, Vascular and Endovascular Surgery Society, Canadian Association of Interventional Cardiology (CAIC), International Society of Hypertension

Europe

Association for European Paediatric and Congential Cardiology, Austrian Heart Foundation, Austrian Society of Cardiology, Belgian Society of Cardiology, British Association for Cardiovascular Prevention and Rehabilitation, British Cardiac Society, British Cardiovascular Society, British Heart Foundation, British Hypertension Society, British Junior Cardiologists Association, Croatian Cardiac Society, European Society of Cardiology, French Society of Cardiology, International Academy of Cardiology, Spanish Society of Cardiology, British Cardiology Society, Albanian Society of Cardiology, Association of Cardiologists of Bosnia & Herzegovina, Belorussian Scientific Society of Cardiologists, British Association of Nursing in Cardiovascular Care, British Congenital Cardiac Association (BCCA), British Heart Failure Society, British Nuclear Cardiology Society, Cardiology Society of Serbia, Cyprus Society of Cardiology, Czech Society of Cardiology, Danish Society of Cardiology, Estonian Society of Cardiology, Finnish Cardiac Society, German Heart Foundation, German Cardiac Society (GCS), Georgian Society of Cardiology, Hellenic Society of Cardiology, Icelandic Society of Cardiology, International Society for Vascular Surgery, Irish Cardiac Society, Kosovo Society of Cardiology, Lithuanian Society of Cardiology, Luxembourg Society of Cardiology, Macedonian FYROM Society of Cardiology, Maltese Cardiac Society, Moldavian Society of Cardiology, Montenegro Society of Cardiology, Moroccan Society of Cardiology, Norwegian Society of Cardiology, Polish Cardiac Society, Portuguese Society of Cardiology, San Marino Society of Cardiology, Slovak Society of Cardiology, Slovenian Society of Cardiology, Spanish Heart Foundation, Swedish Society of Cardiology, Swiss Society of Cardiology, World Heart Federation, The European Society Heart and Lung Transplantation, The Union of Vascular Societies of Switzerland, Swiss Society of Angiology, European Society for Vascular Surgery, Vascular Access Society (VAS), Zurich Heart House

Middle-East

Algerian Society of Hypertension, Armenian Cardiologists Association, Iranian Heart Association, Saudi Heart Association, Emirates Cardiac Society, Gulf Heart Association, Russian Cardiac Society, Russian Society of Cardiology, Ukrainian Association of Cardiology

Asia-Pacific

Asian Pacific Society of Cardiology, Asian Pacific Society of Hypertension, Asian Society for Cardiovascular and Thoracic Surgery, Asian Society of Cardiothoracic Anaesthesia, Asian Society of Cardiovascular Imaging, Association of Black Cardiologists, Association of Cardiologists of Kazakhstan, Association of Pediatric Cardiology, Association of Thoracic and Cardiovascular Surgeons of Asia (ATCA), Australian Cardiovascular Health and Rehabilitation Association, Cardiac Society of Australia & New Zealand, Cardiological Society of India, Chinese Society of Cardiology, Chinese Society of Cardiology, Indonesian Heart Association, Hong Kong College of Cardiology, Hong Kong Society of Paediatric Cardiology, Mongolian Society for Pediatric Cardiology, National Heart Association of Malaysia, Philippine Heart Association, Singapore Cardiac Society, Singapore National Heart Association, Taiwan Society of Cardiology, The Korean Society of Cardiology, The Pan-African Society of Cardiology (PASCAR), Vietnam Heart Association, World Health Organization

 

Interventional Cardiology Conference 2021 Report

Conference Series Llc Ltd hosted the “9^th International Conference on Interventional Cardiology”, during August 09-10, 2021 with the theme, “Cardiac diseases and conditions, Prevailing to COVID-19 situation”, which was a great success. Eminent keynote speakers from various reputed institutions and organizations addressed the gathering with their resplendent presence.

We extend our grateful thanks to all the momentous speakers, conference attendees who contributed towards the successful run of the conference.

Interventional Cardiology Conference 2021 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various latest and exciting innovations in all areas of Cardiology research.

Cardiology 2021 Organizing Committee extends its gratitude and congratulates the Honourable Moderator of the conference, Dr. Lazar B. Davidovic, University of Belgrade, Serbia for remarkable contribution towards smooth functioning of this esteemed event.

Conference Series LLC extends its warm gratitude to all the Honourable Guests and Keynote Speakers of Interventional Cardiology 2021

Jodi J. Akin, CEO & Chairman (Hawthorne Effect), Germany

Samir Rafla, Department of Cardiology, Egypt

Ahmed Zakaria, Departement of internal medicine, Farwaniya hospital, Kuwait

Roshinipriya Ganesin, Department of Medicine, International Medical University Clinical Campus Kluang, Malaysia

Mary Shibuya, Medical Editor, Japanese Research Society of Clinical Anatomy, Japan

Mila Jakovljevic, Director, Sveti Nikola Polyclinic, Croatia

Galya Atanasova, Professor, Medical University Pleven, Bulgaria

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

• Cardiovascular Disease or Risk Reduction
• Acute Coronary Syndromes (ACS)
• Invasive and Interventional cardiology
• The Cardiovascular Impact of COVID-19
• Heart Disease & Failure
• Heart Diagnosis & Medication
• Heart Devices
• Diabetes, Obesity & Stroke
• Pediatric Cardiology
• Cardiac Nursing
• Heart Regeneration
• Cardiology - Future Medicine
• Case Reports on Cardiology

Conference Series LLC Ltd is privileged to felicitate Interventional Cardiology Conference 2021 Organizing Committee, Keynote Speakers, Chairs and the Moderator of the conference whose support and efforts made the conference to move in the path of success. Conference Series llC ltd thanks every individual participant for the enormous, exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Hearts.

Conference Series LLC Ltd therefore is glad to announce its “10th International Conference on Interventional Cardiology, Heart failure & Cardiovascular Medicine” which is going to be held in Tokyo, Japan during April 25-26, 2022. We cordially welcome all the eminent researchers, students and delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cardiology.